Urge Your Representative to Cosponsor ROOT Act Today
ACR urges support for H.R. 5737, the ROOT Act, to fix CMS imaging rules and save Medicare billions. Contact your rep to cosponsor today.
Read moreMain Content
FDA Releases Final Guidance For MQSA Regulation Changes Effective Sept. 10
Aug. 29, 2024
The U.S. Food and Drug Administration (FDA) this week provided notice of final guidance issued by the Center for Devices and Radiological Health, Mammography Quality Standards Act (MQSA) and Regulation Amendments: Small Entity Compliance Guide (SECG). The FDA developed the SECG to explain the actions a small entity must take to comply with the MQSA rule and its implementing regulations.
The March 2023 MQSA rule modernized mammography regulations and specifies that the mammography report given to patients specifies if they have dense or non-dense breast tissue; it includes a prescribed paragraph on the significance of breast density.
The FDA prepared the SECG to help small entities comply with MQSA regulation changes, which take effect Sept. 10.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
The March 2023 MQSA rule modernized mammography regulations and specifies that the mammography report given to patients specifies if they have dense or non-dense breast tissue; it includes a prescribed paragraph on the significance of breast density.
The FDA prepared the SECG to help small entities comply with MQSA regulation changes, which take effect Sept. 10.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
Related ACR News
ACR Urges Commerce to Protect Access to Radiology Devices
ACR urges Commerce to avoid tariffs on imaging tech, warning it could harm patient access, raise care costs, and strain the U.S. healthcare system.
Read moreFederal Government Shutdown: Key Updates
Key information and resources for ACR members regarding the October 2025 U.S. federal government shutdown.
Read more